Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2

Status

Recruiting 4Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3

Conditions

Leukemia, Myeloid, Acute 9Leukemia, Biphenotypic, Acute 4Leukemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Acute Myeloid Leukemia With KMT2A Rearrangement 1

Interventions

Cytarabine 14Cyclophosphamide 12Whole-Body Irradiation 10Methotrexate 9venetoclax 8fludarabine 7Vincristine 7Specimen Handling 7Mycophenolic Acid 7Dexamethasone 7fludarabine phosphate 6Idarubicin 5Hydrocortisone 5Daunorubicin 5Calcium Dobesilate 5Biopsy 5Azacitidine 5revumenib 4calaspargase pegol 4blinatumomab 4X-Rays 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Mercaptopurine 4Filgrastim 4Cyclosporins 4Cyclosporine 4Cladribine 4pegylated granulocyte colony-stimulating factor 3dexamethasone acetate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Biphenotypic, Acute × revumenib × Clear all
NCT06177067 2026-05-04

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

St. Jude Children's Research Hospital

Phase 1 Recruiting
24 enrolled
Other hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT04065399 2026-03-18

AUGMENT-101

Syndax Pharmaceuticals

Phase 1/2 Recruiting
447 enrolled 2 FDA
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06575296 2026-03-05

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

City of Hope Medical Center

Phase 1 Recruiting
27 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07356154 2026-01-21

A Study of Revumenib and Mezigdomide in People With Leukemia

Memorial Sloan Kettering Cancer Center

Phase 1/2 Recruiting
52 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡